Dr. Gulley (M.D., Ph.D., FACP) is a board certified medical oncologist and Director of the Clinical Immunotherapy Group at the National Cancer Institute. He is a clinical investigator within the Medical Oncology Branch and is especially interested immunotherapy for prostate cancer.

He received his medical training at Loma Linda University in their medical scientist training program where he obtained a PhD with his work in tumor immunology as well as an MD. He went to Emory University for a residency in Internal Medicine and then to the National Cancer Institute for a fellowship in Medical Oncology.

Since 1999 Dr. Gulley has been involved in designing and running numerous clinical trials in prostate cancer at the National Cancer Institute. He is the principal investigator on 8 clinical trials and an associate investigator on 22 other trials. He has received numerous awards including a shared NCI Group Merit Award “For major contributions to the field of cancer immunotherapy.” Over the past 5 years, he has authored over 50 original articles, reviews and book chapters on immunotherapy and cancer treatments, and has made numerous presentations at national and international meetings.